Dendreon Corp (DNDN) Financial Statements (2024 and earlier)

Company Profile

Business Address 1301 2ND AVE.
SEATTLE, WA 98101
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments127,297155,153179,622166,641207,418275,211
Cash and cash equivalents66,92190,09792,53087,69492,012130,577
Short-term investments60,37665,05687,09278,947115,406144,634
Receivables30,30627,20334,56034,71136,55239,109
Inventory, net of allowances, customer advances and progress billings70,03163,22354,34696,11691,39589,542
Inventory70,03163,22354,34696,11691,39589,542
Prepaid expense and other current assets20,30822,36122,106
Other undisclosed current assets8,89315,79815,220   
Total current assets:236,527261,377283,748317,776357,726425,968
Noncurrent Assets
Property, plant and equipment113,456118,714125,168132,130139,935144,134
Long-term investments and receivables9,42514,59219,81966,70873,15662,059
Long-term investments9,42514,59219,81966,70873,15662,059
Other noncurrent assets5,2215,1285,666   
Prepaid expense and other noncurrent assets5,5266,0706,789
Total noncurrent assets:128,102138,434150,653204,364219,161212,982
TOTAL ASSETS:364,629399,811434,401522,140576,887638,950
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities65,57465,14764,22275,19874,43575,612
Employee-related liabilities15,70514,50120,14420,82819,04419,869
Accounts payable13,93919,80110,4597,8817,62113,373
Accrued liabilities35,93030,84533,61946,48947,77042,370
Debt2,43630,11830,11430,08530,2292,685
Deferred revenue and credits6,4996,7116,8867,1937,3537,917
Other undisclosed current liabilities(845)(377)2,539(1,721)(1,120)448
Total current liabilities:73,664101,599103,761110,755110,89786,662
Noncurrent Liabilities
Long-term debt and lease obligation575,390568,978562,697556,570550,580572,397
Long-term debt, excluding current maturities573,135566,057559,122552,326545,666566,825
Capital lease obligations2,2552,9213,5754,2444,9145,572
Liabilities, other than long-term debt5,6305,5505,4715,6765,4055,157
Accounts payable and accrued liabilities5,6305,5505,4715,6765,4055,157
Total noncurrent liabilities:581,020574,528568,168562,246555,985577,554
Total liabilities:654,684676,127671,929673,001666,882664,216
Equity
Equity, attributable to parent(299,809)(286,255)(247,651)(161,157)(100,464)(35,907)
Common stock154154153152152152
Additional paid in capital2,002,8052,001,0762,003,2712,001,0281,994,5961,990,205
Accumulated other comprehensive income (loss)39537975(15)91
Accumulated deficit(2,302,807)(2,287,538)(2,251,154)(2,162,412)(2,095,197)(2,026,355)
Total equity:(299,809)(286,255)(247,651)(161,157)(100,464)(35,907)
Other undisclosed liabilities and equity9,7549,93910,12310,29610,46910,641
TOTAL LIABILITIES AND EQUITY:364,629399,811434,401522,140576,887638,950

Income Statement (P&L) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues82,21168,78074,83568,00273,31567,594
Revenue, net82,16368,78074,82867,98273,28667,580
Cost of revenue(37,871)(36,629)(32,222)(46,933)(43,798)(43,375)
Gross profit:44,34032,15142,61321,06929,51724,219
Operating expenses(83,880)(91,859)(150,149)(121,907)(128,488)(126,229)
Other undisclosed operating income37,87136,62932,22246,93343,79843,375
Operating loss:(1,669)(23,079)(75,314)(53,905)(55,173)(58,635)
Nonoperating income (expense)(5)37(156)(10)4041
Investment income, nonoperating52(263)(420)158177(542)
Interest and debt expense(13,647)(13,426)(13,386)(13,458)(13,886)(13,629)
Loss from continuing operations:(15,321)(36,468)(88,856)(67,373)(69,019)(72,223)
Loss before gain (loss) on sale of properties:(15,321)(36,468)(88,856)(67,373)(69,019)(72,223)
Net loss:(15,321)(36,468)(88,856)(67,373)(69,019)(72,223)
Other undisclosed net income attributable to parent5284114158177218
Net loss available to common stockholders, diluted:(15,269)(36,384)(88,742)(67,215)(68,842)(72,005)

Comprehensive Income ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net loss:(15,321)(36,468)(88,856)(67,373)(69,019)(72,223)
Other undisclosed comprehensive loss   (68)   
Comprehensive loss:(15,321)(36,468)(88,924)(67,373)(69,019)(72,223)
Other undisclosed comprehensive income, net of tax, attributable to parent385818624871162
Comprehensive loss, net of tax, attributable to parent:(15,283)(36,410)(88,738)(67,125)(68,948)(72,061)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: